Macrogen Corp. (www.macrogenlab.com) announces that its Clinical Lab that provides clinical NGS services has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.
“Macrogen demonstrates leadership, innovation, and a passionate commitment to standards of excellence while providing the highest quality services, ultimately for patients,” said Bharati Jhaveri, MD, FCAP, chair of the CAP’s Council on Accreditation. “The CAP congratulates Macrogen Corp. on its recent CAP Accreditation.”
The U.S. federal government recognizes the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal to or more-stringent-than the government’s own inspection program.
During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory’s records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.
The facility’s director, Carlos Ruiz, MD, FCAP, was advised of this national recognition and congratulated for the excellence of the services being provided.
“We are very proud at Macrogen Clinical Laboratory to be a CAP Accredited laboratory in Genomic Sequencing,” said Dr. Ruiz, “The future is exciting in finding ways to improve and enhance Clinical applications utilizing whole genome and whole exome sequencing.”